In this study, we want to learn more about the safety and effectiveness of using a personalized vaccine with a drug called pembrolizumab for the treatment of non‐small cell lung cancer (NSCLC) and squamous cell cancer of the head and neck (SCCHN).
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Jared Weiss
Medicine- Oncology
Clinical or Medical
Interventional
Cancer (Head and Neck, Lung)
18-3302